Schizophrenia News: November 2013

  • Researchers in Finland were able to see a significant decrease in schizophrenia symptoms after four weeks of patients treated with 200 mg daily of famotidine.

     

    This drug has been used for treating heartburn since the 1980s.

     

    Thirty individuals diagnosed with schizophrenia participated in the study.  All thirty had been on sickness pension for at least five years.

     

    Famotidine blocks the histamine H2 receptor.  Important neurons in the brain use histamine as their primary signaling substance.

     

    (New treatment for schizophrenia discovered, retrieved on August 12, 2013 from http://zeenews.india.com/news/health . . .)

    Add This Infographic to Your Website or Blog With This Code:

     

    Research finds that even  in Nordic countries with well-developed welfare systems there's evidence of excess mortality.

     

    According to a recent paper: women and men in Denmark, Finland, and Sweden, who had been hospitalized for a psychotic disorder, had a two to three-fold increased risk for dying from a cardiovascular disease.

     

    The study's goal was to compare the mortality by diseases of the circulatory system among patients with bipolar disorder or schizophrenia in the three Nordic countries Denmark, Sweden, and Finland.

     

    The results: Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter.

     

    (Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the nordic countries, retrieved on July 12, 2013 from http://www.ncbi.nlom.nih.gov/pubmed/23826212)

     

    Victorian researchers in Australia are testing a device for the treatment of symptoms of mental illness.  The device would work like a cochlear implant.

     

    According to the report on the perthnow.com Web site: Plastic electrodes implanted in the frontal area of the brain would provide electrical stimulation, improving connections between brain cells.

     

    3D printing technology would embed proteins that promote healthy cell development into the "biologically active" plastic device, for delivery to the exact problem area.

     

    Symptoms of cognitive function and communication have mostly been resistant to current treatment.

     

    More than 1.5 million Australians have depression, schizophrenia and other mental health disorders. 

     

    Professor Xu-Feng Huang, deputy executive director of Illawarra Health and Medical Research Institute hopes that brain wiring disrupted in mental illness can be reconnected.

     

    (Brain device to treat mental illness under development by Victorian researchers retrieved on November 21, 2013 from http://www.perthnow.com.au/news...)

     

Published On: November 21, 2013